Circulating tissue factor‐positive extracellular vesicles and their association with thrombosis in different diseases
- 16 June 2022
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 312 (1), 61-75
- https://doi.org/10.1111/imr.13106
Abstract
Tissue factor (TF) is a procoagulant protein released from activated host cells, such as monocytes, and tumor cells on extracellular vesicles (EVs). TF + EVs are observed in the circulation of patients with various types of diseases. In this review, we will summarize the association between TF + EVs and activation of coagulation and survival in different types of diseases, including cancer, sepsis, and infections with different viruses, such as human immunodeficiency virus (HIV), influenza A virus (IAV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We will also discuss the source of TF + EVs in various diseases. EVTF activity is associated with thrombosis in pancreatic cancer patients and coronavirus disease 2019 patients (COVID-19) and with disseminated intravascular coagulation in cancer patients. EVTF activity is also associated with worse survival in patients with cancer and COVID-19. Monocytes are the major sources of TF + EVs in sepsis, and viral infections, such as HIV, Ebola virus, and SARS-CoV-2. In contrast, alveolar epithelial cells are the major source of TF + EVs in bronchoalveolar lavage fluid in COVID-19 and influenza A patients. These studies indicate that EVTF activity could be used as a biomarker to identify patients that have an increased risk of coagulopathy and mortality.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (1R35HL155657)
This publication has 132 references indexed in Scilit:
- Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activityThrombosis Research, 2012
- Differential contributions of monocyte‐ and platelet‐derived microparticles towards thrombin generation and fibrin formation and stabilityJournal of Thrombosis and Haemostasis, 2011
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesiclesCellular and Molecular Life Sciences, 2011
- Increased microparticle tissue factor activity in cancer patients with Venous ThromboembolismThrombosis Research, 2010
- Cellular sources of tissue factor in endotoxemia and sepsisThrombosis Research, 2010
- Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivoThe Journal of Experimental Medicine, 2009
- Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic miceJournal of Thrombosis and Haemostasis, 2009
- Pyroptosis: host cell death and inflammationNature Reviews Microbiology, 2009
- Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancerJournal of Thrombosis and Haemostasis, 2008
- Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?Journal of Thrombosis and Haemostasis, 2007